Addyi
produces a drug to treat acquired, generalized hypoactive sexual desire disorder in women... Read moreAddyi
produces a drug to treat acquired, generalized hypoactive sexual desire disorder in women... Read more
News
Apr 29, 2026
PR Newswire
Press Release: Addyi : SPROUT PHARMACEUTICALS, MAKERS OF ADDYI (FLIBANSERIN), NAMED ONE OF THE 10 MOST INFLUENTIAL HEALTH AND LIFE SCIENCE COMPANIES OF 2026 BY TIME
Jan 29, 2026
StreetInsider
Press Release: Addyi : Sprout Pharmaceuticals' Addyi (flibanserin) Named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards
Jan 08, 2026
PR Newswire
Press Release: Addyi : PHIL and Sprout Pharmaceuticals Expand Their Affordable Direct-to-Patient Access Program for Addyi(flibanserin)
Sep 04, 2025
PR Newswire
Press Release: Addyi : Addyi Marks a Decade of Leadership in Women's Sexual Health
Jul 24, 2025
PR Newswire
Press Release: Addyi : FDA Grants Priority Review for Addyi (flibanserin) Paving the Way for Expanded Access to Treat Low Sexual Desire in Postmenopausal Women
Dec 11, 2020
WRAL TechWire
Addyi: Sprout Pharmaceuticals maker of female "Viagra," sells options and securities in debt round
Sep 15, 2020
STAT News
Addyi: STAT Plus: FDA warns Sprout for failing to mention risks in radio ad for Addyi
Sep 11, 2019
BioPortfolio
Addyi: At the insistence of regulators Sprout Pharmaceuticals has recanted statements that indicated the FDA had eased various restrictions concerning its controversial female libido pill. httpsbuff.ly2Q3GGFjÂ
Sep 04, 2019
Fortune
Addyi: Sprout, The Company Focused on Women's Sexual Pleasure, Raises $20 Million: Term Sheet
Sep 04, 2019
PR Newswire
Press Release: Addyi : FDA Removes Alcohol Ban with Addyi - the First-and-Only Non-Hormonal Treatment for Hypoactive (Low) Sexual Desire Disorder (HSDD)
Addyi Competitors
1
2
3
4
5
6
7
8
9
10